GlassScriptPhysician profile
Sarah Dubinsky
NPI 1922721695
$5,293.69
in general payments reported to CMS, 2019-2025
24 companies · $1,374 in 2025
The $1,374 reported for 2025 was more than what 89% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $982 · 2024: $2,937 · 2025: $1,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,228 · Education: $65.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,227.70 |
| Education | $65.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $761.56 | 2023-2025 | |
| Arcutis Biotherapeutics, INC. | $599.82 | 2023-2025 | Zoryve |
| Janssen Biotech, INC. | $489.63 | 2023-2025 | Tremfya |
| Genzyme Corporation | $417.03 | 2023-2025 | |
| Incyte Corporation | $400.44 | 2023-2025 | Opzelura |
| Dermavant Sciences, INC. | $347.22 | 2023-2024 | Vtama |
| Amgen INC. | $345.21 | 2023-2025 | Otezla, Otezla |
| Regeneron Healthcare Solutions, INC. | $318.93 | 2023-2025 | Dupixent |
| Leo Pharma INC. | $293.83 | 2024-2025 | Adbry, Anzupgo |
| Sun Pharmaceutical Industries INC. | $213.60 | 2023-2025 | Winlevi, Absorica Ld |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $165.81 | 2023-2024 | Cabtreo, Jublia |
| Almirall LLC | $141.18 | 2024-2025 | Klisyri |
| E.R. Squibb & Sons, L.L.C. | $117.76 | 2023 | Sotyktu |
| Lilly USA, LLC | $115.18 | 2023-2024 | Olumiant, Ebglyss, Taltz |
| Ucb, INC. | $114.53 | 2023-2025 | Bimzelx, Cimzia |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $111.53 | 2023-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Mayne Pharma Commercial LLC | $110.25 | 2023 | |
| Verrica Pharmaceuticals INC. | $83.50 | 2023-2024 | Ycanth |
| Organon LLC | $46.64 | 2025 | Vtama |
| Sebela Pharmaceuticals INC. | $23.87 | 2023 | Pramosone, Naftin |
| Lnhc, INC | $22.73 | 2025 | Zelsuvmi |
| Botanix Sb INC | $21.24 | 2025 | Sofdra |
| Galderma Laboratories, L.P. | $18.45 | 2025 | Nemluvio |
| Smith+Nephew, INC. | $13.75 | 2024 | Collagenase Santyl |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sarah Dubinsky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.